Eli Lilly has escalated its legal actions against compounding pharmacies producing unauthorized versions of its GLP-1 medications, Mounjaro and Zepbound, which contain tirzepatide as the active ingredient
Balanced diets with omega-3s and fewer processed foods support brain health
Cell Rep Med 5(10):101778
However, in clinical practice higher doses up to 2.0 mg are used in patients with T2D, and up to 2.4 mg/week in patients with obesity without T2D
GLP-1s are shaping how people eat, drink, shop, and exercise, and brands need to be paying close attention to these trends. Also referencing the KFF survey, Shil Kothari, president at Gateway Health Alliances Inc., Fairfield, Calif., explains that the awareness of GLP-1s mean that beverage manufacturers must play a proactive role in offering solutions that support those using these medications